Valens Announces Formation of Advisory Board
October 18 2018 - 8:30AM
InvestorsHub Cannabis NewsWire
KELOWNA, BC
-- Oct. 18, 2018 --
InvestorsHub NewsWire -- Valens GroWorks Corp. (CSE: VGW) (the
"Company" or
"Valens"), a
multi-licensed, vertically integrated provider of cannabis products
and services utilizing proprietary extraction processes is pleased
to announce that it has formed an advisory board to assist in
implementing the Company's current strategic plans and identify
means to capitalize on future growth opportunities.
The advisory
board will be tasked with:
- Leveraging marketing
initiatives;
- Assisting in the
development of a consumer-packaged goods strategy for Valens
branded products;
- Supporting international
expansion plans; and
- Developing strategic
relationships in the industry.
The Company has initially
appointed Mr. Phil
Donne and Mr. Brett Channer to the advisory
board.
Mr. Donne's background in
the food and brand / communication industries extends over 30
years, spans 8 countries and incorporates rebrands, restructures,
re-launches and bold brand and communication initiatives. From
foundation experience at General Mills and Coca Cola up to his last
role as President / CEO of Campbell Company of Canada, Mr. Donne's
bias has been to truly push the status quo and to spark innovation
to achieve new levels of potential and awareness. His years
at Campbell's witnessed a spurring of the health and wellness
renovation and relaunch of the entire soup portfolio. At
Campbell's, Mr. Donne also led the first "meal replacement"
offering in a can that was used to help in the fight against hunger
both domestically and abroad. With Kellogg's, Mr. Donne
gained experience across Europe as President in several
posts. Returning to Canada as CEO of Kellogg Canada, he led a
relaunch of the business that featured the breakthrough
introduction of North
America's first "meal replacement" cereal, Vector which
remains the single largest new cereal product of the last 20
years.
Mr. Channer has over 25
years of marketing industry experience leading businesses as the
CEO, President, and Chief Creative Officer and is now the founder
of Mass Minority, a media studio with patent pending technology
that works with creative content to outperform the market. Mass
Minority is enjoying exponential growth and in less than three
years has become a top agency in Canada. Before starting Mass
Minority, Mr. Channer created the agency start up Red Lion for the Publicis World
Wide Group, a digitally rooted company that shaped brand behaviour.
Profitable in its first year, Red Lion became a change agent
for Publicis and for clients seeking a new way to connect with
customers. At Saatchi & Saatchi, Mr. Channer worked into
the role of CEO and CCO. He was responsible for
leading Saatchi
Canada to "Most Improved Agency in Canada" as recognized in Strategy
Magazine, as well as one of the top 10 most creative agencies
in Canada. Becoming
one of the top performing offices for growth in the Saatchi
Network, Mr. Channer was the first Canadian to be invited onto the
Saatchi Worldwide Board where he had shared responsibilities in the
company's global performance.
"The creation of this
advisory board marks the next exciting stage of development for
Valens. With the initial appointment of Phil and Brett, each of
whom bring a unique skillset and vast experience to the Company, we
look forward to working with these leaders to shape the future of
marketing in the Canadian cannabis space and develop a leading
Valens product brand we can proudly share with the market," says
Valens GroWorks Corp. CEO, Tyler
Robson.
Option
Grant
The Company granted
2,652,000 options to purchase common shares of the Company
exercisable at a price of $1.95 per share and
expiring on October
13, 2023, to employees, officers and consultants of the
Company. The options vest quarterly over a three-year period and
are granted pursuant to the terms of the Company's stock option
plan, subject to regulatory approval.
About
Valens GroWorks
Valens GroWorks Corp. is
a vertically integrated provider of Canadian cannabis products
developed from our proprietary extraction techniques, with three
wholly-owned subsidiaries located in and around Kelowna, BC.
Subsidiary Valens
Agritech ("VAL") holds a license to cultivate and
produce oil as a Licensed Producer ("LP") under the ACMPR, and a
Dealer's License under Health Canada. VAL also has a supply
agreement with Canopy Growth Corporation under their extensive
CraftGrow distribution network. Subsidiary Supra THC Services is a
Health Canada licensed ISO 17025 accredited cannabis testing lab
providing sector-leading analytical services and has partnered with
Thermo Fisher Scientific to develop a Centre of Excellence in Plant
Based Medicine Analytics. Subsidiary Valens Farms is in the process
of becoming a purpose-built facility in compliance with European
Union (EU) Good Manufacturing Practices (GMP) standards, ensuring
the product from this facility can be exported anywhere in the
world where Cannabis is nationally legal for medical or adult usage
purposes. For more information, please visit http://valensgroworks.com.
The Company's investor deck can be found specifically
at http://valensgroworks.com/investors/
Notice regarding Forward
Looking Statements
This news release
contains certain "forward-looking statements" within the meaning of
such statements under applicable securities law. Forward-looking
statements are frequently characterized by words such as
"anticipates", "plan", "continue", "expect", "project", "intend",
"believe", "anticipate", "estimate", "may", "will", "potential",
"proposed", "positioned" and other similar words, or statements
that certain events or conditions "may" or "will" occur. These
statements are only predictions. Various assumptions were used in
drawing the conclusions or making the projections contained in the
forward-looking statements throughout this news release.
Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made and are subject
to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from
those projected in the forward-looking statements. The Corporation
is under no obligation, and expressly disclaims any intention or
obligation, to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as expressly required by applicable
law.
The CSE or other
regulatory authority has not reviewed, approved or disapproved the
contents of this press release. We seek Safe
Harbour.
SOURCE Valens GroWorks Corp.
For further information: Scott Young,
Telephone: +1.705.888.2756
Valens Groworks (CSE:VGW)
Historical Stock Chart
From Nov 2024 to Dec 2024
Valens Groworks (CSE:VGW)
Historical Stock Chart
From Dec 2023 to Dec 2024